$0.96
+0.03 (+3.32%)
Open$0.98
Previous Close$0.93
Day High$0.98
Day Low$0.95
52W High$605.00
52W Low$225.30
Volume—
Avg Volume40.5K
Market Cap168.56M
P/E Ratio—
EPS$-1.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,078.9% upside
Current
$0.96
$0.96
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 918.13M | 892.86M | 56.95M |
| Net Income | -117,166,412 | -102,547,671 | 10.61M |
| Profit Margin | -28.4% | -27.0% | 18.6% |
| EBITDA | -62,559,282 | -57,795,699 | 17.54M |
| Free Cash Flow | — | — | 14.62M |
| Rev Growth | +2.8% | +2.8% | -4.9% |
| Debt/Equity | 0.46 | 0.46 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |